Not Tagged
Not Tagged
['leusm']
dr. jeyakumar from presents on cd22-targeted car t-cell therapy for r/r b-all; prior ino allowed if &gt;3m ago and still cd22+. 16 pts treated (19 enrolled), incl 8 peds &amp; 8 adult pts. 7d manufacturing feasible in most. 1 gr3 crs, 1/1 gr3/gr4 icans. 1/2 #leusm #ash22
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????